These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 23378575)
1. Chlamydia trachomatis clinical isolates identified as tetracycline resistant do not exhibit resistance in vitro: whole-genome sequencing reveals a mutation in porB but no evidence for tetracycline resistance genes. O'Neill CE; Seth-Smith HMB; Van Der Pol B; Harris SR; Thomson NR; Cutcliffe LT; Clarke IN Microbiology (Reading); 2013 Apr; 159(Pt 4):748-756. PubMed ID: 23378575 [TBL] [Abstract][Full Text] [Related]
2. Effects of sustained antibiotic bactericidal treatment on Chlamydia trachomatis-infected epithelial-like cells (HeLa) and monocyte-like cells (THP-1 and U-937). Mpiga P; Ravaoarinoro M Int J Antimicrob Agents; 2006 Apr; 27(4):316-24. PubMed ID: 16527461 [TBL] [Abstract][Full Text] [Related]
4. In vitro tetracycline susceptibility of Chlamydia trachomatis in clinical specimens. Hsu AH; Knelsen B; Kasatiya S Antonie Van Leeuwenhoek; 1987; 53(3):191-6. PubMed ID: 3662489 [TBL] [Abstract][Full Text] [Related]
5. Partial characterization of Chlamydia trachomatis isolates resistant to multiple antibiotics. Jones RB; Van der Pol B; Martin DH; Shepard MK J Infect Dis; 1990 Dec; 162(6):1309-15. PubMed ID: 2230260 [TBL] [Abstract][Full Text] [Related]
7. In vitro evaluation of activities of azithromycin, erythromycin, and tetracycline against Chlamydia trachomatis and Chlamydia pneumoniae. Welsh LE; Gaydos CA; Quinn TC Antimicrob Agents Chemother; 1992 Feb; 36(2):291-4. PubMed ID: 1318677 [TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms of Mestrovic T; Ljubin-Sternak S Front Biosci (Landmark Ed); 2018 Jan; 23(4):656-670. PubMed ID: 28930567 [No Abstract] [Full Text] [Related]
9. Characterization and functional analysis of PorB, a Chlamydia porin and neutralizing target. Kubo A; Stephens RS Mol Microbiol; 2000 Nov; 38(4):772-80. PubMed ID: 11115112 [TBL] [Abstract][Full Text] [Related]
10. [Minimum inhibitory concentration and minimum bactericidal concentration of tetracycline and erythromycin in 35 recent Munich isolates of Chlamydia trachomatis]. Korting HC; Hartinger A Hautarzt; 1988 Mar; 39(3):161-5. PubMed ID: 3378887 [TBL] [Abstract][Full Text] [Related]
11. In vitro susceptibility of recent clinical isolates of Chlamydia trachomatis to macrolides and tetracyclines. Samra Z; Rosenberg S; Soffer Y; Dan M Diagn Microbiol Infect Dis; 2001 Mar; 39(3):177-9. PubMed ID: 11337185 [TBL] [Abstract][Full Text] [Related]
12. In vitro activities of tetracycline & ciprofloxacin against Chlamydia trachomatis isolates from conjunctivitis patients. Madhavan HN; Roy S; Malathy J Indian J Med Res; 1996 Mar; 103():138-41. PubMed ID: 9062038 [TBL] [Abstract][Full Text] [Related]
13. Comparative in vitro susceptibility of a tetracycline-resistant Chlamydia trachomatis strain isolated in Toulouse (France). Lefèvre JC; Lépargneur JP Sex Transm Dis; 1998 Aug; 25(7):350-2. PubMed ID: 9713914 [TBL] [Abstract][Full Text] [Related]
14. Growth and development of tetracycline-resistant Chlamydia suis. Lenart J; Andersen AA; Rockey DD Antimicrob Agents Chemother; 2001 Aug; 45(8):2198-203. PubMed ID: 11451674 [TBL] [Abstract][Full Text] [Related]
15. Tetracycline-resistant Chlamydia trachomatis in Toulouse, France. Lefevre JC; Lepargneur JP; Guion D; Bei S Pathol Biol (Paris); 1997 May; 45(5):376-8. PubMed ID: 9296087 [TBL] [Abstract][Full Text] [Related]
16. Frequency of spontaneous mutations that confer antibiotic resistance in Chlamydia spp. Binet R; Maurelli AT Antimicrob Agents Chemother; 2005 Jul; 49(7):2865-73. PubMed ID: 15980362 [TBL] [Abstract][Full Text] [Related]
17. In vitro assays of the efficacy of antimicrobial agents in controlling Chlamydia trachomatis propagation. Lee CK; Bowie WR; Alexander ER Antimicrob Agents Chemother; 1978 Mar; 13(3):441-5. PubMed ID: 162541 [TBL] [Abstract][Full Text] [Related]
18. Incidence of antibiotic resistance in Campylobacter jejuni isolated in Alberta, Canada, from 1999 to 2002, with special reference to tet(O)-mediated tetracycline resistance. Gibreel A; Tracz DM; Nonaka L; Ngo TM; Connell SR; Taylor DE Antimicrob Agents Chemother; 2004 Sep; 48(9):3442-50. PubMed ID: 15328109 [TBL] [Abstract][Full Text] [Related]
19. Nationwide surveillance of the antimicrobial susceptibility of Chlamydia trachomatis from male urethritis in Japan. Takahashi S; Hamasuna R; Yasuda M; Ishikawa K; Hayami H; Uehara S; Yamamoto S; Minamitani S; Kadota J; Iwata S; Kaku M; Watanabe A; Sato J; Hanaki H; Masumori N; Kiyota H; Egawa S; Tanaka K; Arakawa S; Fujisawa M; Kumon H; Wada K; Kobayashi K; Matsubara A; Matsumoto T; Eto M; Tatsugami K; Kuroiwa K; Ito K; Hosobe T; Hirayama H; Narita H; Yamaguchi T; Ito S; Sumii T; Kawai S; Kanokogi M; Kawano H; Chokyu H; Uno S; Monden K; Kaji S; Kawahara M; Takayama K; Ito M; Yoshioka M; Kano M; Konishi T; Kadena H; Nishi S; Nishimura H; Yamauchi T; Maeda S; Horie M; Ihara H; Matsumura M; Shirane T; Takeyama K; Akiyama K; Takahashi K; Ikuyama T; Inatomi H; Yoh M J Infect Chemother; 2016 Sep; 22(9):581-6. PubMed ID: 27452428 [TBL] [Abstract][Full Text] [Related]
20. High dynamic range detection of Chlamydia trachomatis growth by direct quantitative PCR of the infected cells. Eszik I; Lantos I; Önder K; Somogyvári F; Burián K; Endrész V; Virok DP J Microbiol Methods; 2016 Jan; 120():15-22. PubMed ID: 26578244 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]